Culture

Social distancing in the natural world: Strategies to detect and avoid disease

image: Chimpanzee sitting alone. Members of the species are known to distance themselves from sick individuals.

Image: 
Dominik Scythe on Unsplash

The notion of social distancing rose to public prominence approximately a year ago, when health officials began recommending it as a way to slow the spread of the novel SARS-CoV-2 virus. Despite the novelty of the concept among many contemporary human audiences, social distancing has considerable precedent among animals.
Writing in BioScience, Mark Butler of Florida International University and Donald C. Behringer of the University of Florida outline the role of social distancing in nature and compare it with its human counterpart. They describe numerous animals in which distancing has evolved, including guppies, chimpanzees, birds, ants, and mice, among many others.

Often, say the authors, social distancing can mark substantial behavioral changes in otherwise highly social species. Butler and Behringer describe the seasonal migrations of spiny lobsters, which occur "en masse, strung out on the seafloor in dramatic single-file lines or queues." However, because juveniles are particularly susceptible to a virus known as PaV1, which can kill 90% of those infected, healthy lobsters detect and refuse to shelter alongside their diseased conspecifics.

Similarly, say the authors, chimpanzees are known to ostracize unwell group members, such as those infected with polio, and are also thought to benefit from a general avoidance of individuals outside their immediate group. Further examples abound, including among highly social house finches, which avoid experimentally sickened members of the same species, and three-spined stickleback fish, which avoid schools that contain ectoparasite-infected individuals. Some animals even deploy other strategies that resemble humans' disease precautions, such as ants that "use poisons to disinfect their colonies and prevent epizootics."

According to the authors, a key to animals' successful deployment of social distancing lies in their ability to effectively use cues--often olfactory--to detect sickened individuals. Indeed, animals are often able to "use social distancing effectively and efficiently." In contrast, humans are typically forced to rely on low-accuracy visual or auditory cues, such as feverish appearance or coughing, highlighting the importance of diagnostic testing for the effective reduction of disease transmission.

Butler and Behringer suggest that future study may further illuminate and inform human responses to disease: "The examples of social distancing in wild animals in the present article, although they are compelling, are likely a small fraction of those that actually exist in nature and reflect the limited investigations conducted thus far on this phenomenon in the wild. What lessons might we learn about the human experience with pandemics from an expanded view of diseases, their spread, and their prevention in nature?"

Credit: 
American Institute of Biological Sciences

Racism and anti-gay discrimination heighten risk for arrest and incarceration

New research by Morgan Philbin, PhD, at Columbia University Mailman School of Public Health and colleagues looks at why Black young men who have sex with men (YMSM) are disproportionately subject to high rates of arrest and incarceration. They find that perceived racial discrimination, sexual orientation discrimination, and HIV-status discrimination are all associated with risk for criminal justice involvement in this population.

The research appears in the journal Stigma and Health.

Various studies have shown that Black men are imprisoned at nearly seven times the rate of white men; sexual minority young adults are nearly three times more likely to report being criminally sanctioned compared to their heterosexual peers; and the rate of HIV among prisoners is multiple times higher than the general population. Discrimination can occur at all stages of criminal justice involvement, from differential enforcement and/or threats of violence by police officers to court proceedings and sentencings.

The longitudinal study of 465 Black YMSM at risk for HIV in North Carolina explored discrimination at baseline and finds that perceived racism was the strongest predictor of subsequent criminal justice involvement (29 percent increased odds) followed by perceptions of sexual orientation discrimination (12 percent increased odds) and HIV discrimination (6 percent increased odds).

Unlike most research on predictors of criminal justice involvement that focus on individual-level factors such as race, homelessness, employment, or substance use, the new study examines community- and structural-level drivers--specifically, experiences of discrimination.

"Discrimination, in this instance related to race, sexual identity and HIV, is an important driver of health and life opportunities because it directly influences physical and mental health outcomes and can constrain access to education, jobs, and housing," says Philbin, the study's first author and Columbia Mailman School assistant professor of sociomedical sciences. "As we see in our new study, perceived discrimination--especially the experience of racism--placed the men in this study at an increased risk for arrest and incarceration."

While some studies have examined discrimination in the context of health outcomes like mental illness, these studies usually focused on single categories of discrimination--not intersectional discrimination of the kind experienced by individuals in this study. "To better understand the lived realities of people burdened with overlapping forms of discrimination, we must account for the compounding nature of these intersecting axes of social inequality," says Philbin. "We find that experiences of racism and discrimination based on sexual orientation and HIV status combine to raise these young men's risk for criminal justice involvement."

Participants completed four online surveys over the course of one year to assess the three predictors at baseline and criminal justice involvement at 3, 6, and 12-month follow-up (the study excluded men with criminal justice involvement at baseline). The researchers assessed discrimination through survey questions asking whether participants were, for example, treated with hostility/coldness by strangers, rejected by a potential sexual/romantic partner, denied a place to live, denied a job, and physically assaulted due to their race, sexual orientation; they also explored how individuals living with HIV were treated within their community.

Looking ahead, future research could focus on Black YMSM in other states beyond North Carolina to see if outcomes differ by geographic location. The research could also examine the effect of overlapping forms of discrimination in other groups, such as sexual minority Black women, Black transgender women, and other YMSM of color.

Credit: 
Columbia University's Mailman School of Public Health

Making good decisions about COVID-19

With the COVID-19 pandemic entering its second year, the challenges faced both by individuals and nations remain substantial. While notable medical advancements in the treatment of COVID-19 have been made, a host of questions about how to live with it and how to work to end it remain active.

Carnegie Mellon University researchers David Rode and Paul Fischbeck explore these questions in a new article, "On ambiguity reduction and the role of decision analysis during the pandemic," published in a special issue of the journal Risk Analysis dealing with the COVID-19 pandemic. One of Carnegie Mellon's traditional strengths is its multidisciplinary approach to decision making and Rode and Fischbeck suggest that the decision sciences collectively should have a major role to play in dealing with the virus.

The sciences and medicine are not the only fields struggling with the pandemic.

"In a very real sense, all of us, as individuals, face significant decisions about how to organize our lives right now," said Rode, adjunct research faculty with the Carnegie Mellon Electricity Industry Center. "These decisions range from simple questions, such as the safety of grocery shopping in person or air travel to the complex, such as government policies dealing with mandatory quarantines and compulsory vaccination."

In their article, Rode and Fischbeck note that many of the key decisions facing individuals, corporations and governments all depend on two basic values: the probability a person has the virus and the probability that person transmits the virus.

"The problem is that when we wrote the article neither of those values was known with any degree of certainty," said Fischbeck, professor of Social and Decision Sciences and Engineering and Public Policy. "Without those probabilities, there is ambiguity, which is a difficult environment in which to work for most decision makers."

"In order to reduce this ambiguity," noted Rode, "it's important to collect the right data."

This means collecting data on randomized samples of the population--not just people with symptoms. According to Rode and Fischbeck, this should have been done from the start.

"When the virus first became apparent," said Fischbeck, "testing resources were scarce and largely confined to people already displaying symptoms."

The problem, according to Rode and Fischbeck, was that such testing provided no useful information to guide decision making, and rarely impacted clinical decision making, since patients displaying symptoms were treated without regard to their test results.

"While useful, of course, for those individuals to know their status, this limited, non-randomized testing produced almost no value to policymakers trying to develop responses to the pandemic," said Rode. "How do you advise people to engage, or not engage, in certain activities if you can't determine how risky those activities are?"

"Even today, although we have a great deal more information about infections, we face the same ambiguities regarding wearing masks and vaccination," said Fischbeck. "The experts initially said people shouldn't wear masks; then masks only prevented infected people from spreading the virus but did not protect the wearer from catching it; then masks were effective in doing both; and then two weeks ago wearing two or three masks was 'common sense' and today, there are as of yet no benefits seen in wearing two masks. This ambiguity endures because we don't have the right data."

One of the key missing pieces of information has been the number of "hidden" cases, or undiagnosed individuals who have the virus, but do not display symptoms. These people are still capable of transmitting the virus, but because they are asymptomatic, they may take fewer precautions.

"We had only very rough ideas of the size of this population, because there was virtually no testing of asymptomatic people early on," said Rode. "This is the sort of information that large-scale randomized testing would reveal."

The article notes that, without this information, many mitigating strategies put in place are essentially "security theater"-- actions that make people feel safer without having an appreciable impact on actual risk. Or actions that incur costs in return for unknown benefits. How large a problem are asymptomatic vaccinated people?

In addition to the challenges created by an absence of data, Rode and Fischbeck raise potential problems that could arise from the presence of data. In the article, they write "disclosure informs, but it also divides."

"We mean that the availability of detailed demographic information on population infection rates must be treated with extreme caution," said Fischbeck.

"If 'certificates of immunity' or 'vaccine passports' are put in place, are groups with historically limited access to health care effectively barred from large aspects of public life? Should this form of COVID 'redlining' or 'profiling' be illegal, even if it is useful in limiting the spread of the virus?" said Rode. "There are important policy and ethical questions that must be part of the discussion, even if having the information would make society as a whole better off."

These questions, Rode and Fischbeck argue, create a clear need for the decision sciences to have a seat at the policy table.

The authors conclude that COVID-19 -- and future viruses like it -- are public health crises and solid, objective data are necessary to confront them. Reducing the ambiguity surrounding base rates and transmission rates is of considerable value to creating public health policy when testing is properly directed. But selective or misinterpreted data can also be a "virus." Released unintentionally or maliciously across social media, this "information virus" could cause societal harm to linger long after the physical harm is resolved. Careful application of the decision analyst's tools is essential to traverse this uncharted territory.

Credit: 
Carnegie Mellon University

Relaxed precautions, not climate, the biggest factor driving wintertime COVID-19 outbreaks

Wintertime outbreaks of COVID-19 have been largely driven by whether people adhere to control measures such as mask wearing and social distancing, according to a study published Feb. 8 in Nature Communications by Princeton University researchers. Climate and population immunity are playing smaller roles during the current pandemic phase of the virus, the researchers found.

The researchers -- working in summer 2020 -- ran simulations of a wintertime coronavirus outbreak in New York City to identify key factors that would allow the virus to proliferate. They found that relaxing control measures in the summer months led to an outbreak in the winter regardless of climate factors.

"Our results implied that lax control measures -- and likely fatigue with complying with control measures -- would fuel wintertime outbreaks," said first author Rachel Baker, an associate research scholar in Princeton's High Meadows Environmental Institute (HMEI). Baker and her co-authors are all affiliated with the HMEI Climate Change and Infectious Disease initiative.

"Although we have witnessed a substantial number of COVID-19 cases, population-level immunity remains low in many locations," Baker said. "This means that if you roll back enforcement or adherence to control measures, you can still expect a large outbreak. Climate factors including winter weather play a secondary role and certainly don't help."

The researchers found that even maintaining rigid control measures through the summer can lead to a wintertime outbreak if climate factors provided enough of a boost to viral transmission. "If summertime controls are holding the transmissibility of coronavirus at a level that only just mitigates an outbreak, then winter climate conditions can push you over the edge," Baker said. "Nonetheless, having effective control measures in place last summer could have limited the winter outbreaks we're now experiencing."

Cases have climbed in many northern hemisphere locations since November. In the United States, spikes in COVID-19 cases are thought to be tied to increased travel and gatherings for Thanksgiving and Christmas. Notably, outbreaks were recorded in temperate locations such as Los Angeles in addition to regions with much colder conditions, Baker said. At the same time, large outbreaks were observed in South Africa from November to January, which are that country's summer months.

"The greater incidence of COVID-19 in various environs really speaks to the climate's limited role at this stage," Baker said.

In May, the same authors published a paper in the journal Science suggesting that local climate variations would be unlikely to affect the coronavirus pandemic. The paper suggested that hopes that the warmer conditions of summer would slow the transmission of the novel coronavirus, SARS-CoV-2, in the northern hemisphere were unrealistic.

Gabriel Vecchi, a professor of geosciences and the High Meadows Environmental Institute and co-author of both studies, said that the virus currently spreads too quickly and that people are too susceptible for climate to be a determining factor.

"The influence of climate and weather on infection rates should become more evident -- and thus a potentially useful source of information for disease prediction -- as growing immunity moves the disease into endemic phases from the present epidemic stage," Vecchi said.

The most recent study provides insight on how scientists can determine the impact of various factors on the virus at various times, said co-author C. Jessica Metcalf, associate professor of ecology and evolutionary biology and public affairs and an HMEI associated faculty member.

"An important challenge that we tackle here is balancing the role of many potential factors on the trajectory of the epidemic," Metcalf said. "As the pandemic progresses, both natural and vaccinal immunity will play an increasing role, underscoring the importance of developing a handle on the landscape of immunity."

Critical factors to consider when projecting the future of COVID-19 are emerging variants of the virus, as well as how efforts to contain coronavirus have changed other diseases, said co-author Bryan Grenfell, the Kathryn Briger and Sarah Fenton Professor of Ecology and Evolutionary Biology and Public Affairs and associated faculty in HMEI.

In November, Grenfell and his co-authors in the Climate Change and Infectious Disease initiative published a paper in the Proceedings of the National Academy of Sciences that non-pharmaceutical interventions (NPIs) such as mask wearing and social distancing could result in large, delayed outbreaks of endemic diseases such as influenza and respiratory syncytial virus (RSV).

"The interaction between NPIs and immunity will become even more complex as a variety of vaccines are deployed and new viral variants arise," Grenfell said. "Understanding the impact of these variables underlines the importance of immune surveillance and greatly expanded viral sequencing."

Additional authors of the current paper include Wenchang Yang, an associate research scholar in geosciences at Princeton.

Credit: 
Princeton University

Ancient Amazonian farmers fortified valuable land they had spent years making fertile to protect it

image: excavations

Image: 
Mark Robinson

Ancient Amazonian communities fortified valuable land they had spent years making fertile to protect it from conflict, excavations show.
Farmers in Bolivia constructed wooden defences around previously nutrient-poor tropical soils they had enriched over generations to keep them safe during times of social unrest.
These long-term soil management strategies allowed Amazonians to grow nutrient demanding crops, such as maize and manioc and fruiting trees, and this was key to community subsistence. These Amazonian Dark Earths, or Terra Preta, were created through burning, mulching, and the deposition of organic waste.
It was known that some communities built ditches and embankments, known locally as a zanja, around their settlements, which had suggested to act as a defensive structure. The examples from Bolivia were specifically constructed to also enclose the enriched soil and this is the first evidence of an additional fortification built in the ditch, demonstrating how important communities felt it was to protect their investment in the land.
Excavations, at the Versalles archaeological site along the Iténez River in the Bolivian Amazon, provide the first archaeological evidence that communities in the region built wooden palisades along with earthworks. The construction circles the outer perimeter of the village, enclosing and protecting homes and the enriched soil and forest.
Researchers had long speculated on the function of the zanjas and whether there had also been a palisade structure, but until now no direct evidence of a wooden construction had been found. The harsh tropical climate is unfavourable for the preservation of wooden architecture, but through careful excavation, the decomposed remains of the construction posts were detected in the soil. It is not possible to know what the structure would have looked like.
Archaeological analysis show that those living in Versalles began enriching soils around 500 BC. After almost two millennia, the zanja was constructed around AD 1300, at the same time as social unrest spread across Amazonia. The fortifications were later remodelled, including the addition of the palisade, around AD 1628 to 1803. Archaeological excavations suggests the community continued to thrive during this time, creating elaborate ceramics and producing a diversity of foods from staple crops to fruits and nuts, alongside fish and hunted animals.
The research, published in the journal Geoarchaeology, was conducted in collaboration with the modern Versalles community, by Dr.Mark Robinson and Professor. Jose Iriarte from the University of Exeter, Dr. Carla Jaimes?Betancourt, from the University of Bonn, Dr. Sarah Elliott, from Bournemouth University, and Dr. Yoshi Maezumi, from the University of Amsterdam, with students from the UK and Bolivia participating in excavations.
Dr Robinson said: "This is further evidence the Amazon is not a pristine place, untouched by human hands. People have had a great impact on the ecology of the rainforest. Communities invested heavily, generation after generation, to enrich the natural resources around them. As broad Amazon-wide social-unrest spread, the community felt the need to protect the resources into which they and their ancestors had invested so much."

Credit: 
University of Exeter

Sonoporation: Underlying mechanisms and applications in cellular regulation

Announcing a new article publication for BIO Integration journal. In this review article the authors Yue Li, Zhiyi Chen and Shuping Ge from First Affiliated Hospital of University of South China, Hengyang, China and Tower Health and Drexel University, Philadelphia, PA, USA summarize current state of the art applications of microbubble-cell interactions and sonoporation effects to cellular functions.

Ultrasound combined with microbubble-mediated sonoporation has been applied to enhance drug or gene intracellular delivery. Sonoporation leads to the formation of openings in the cell membrane, triggered by ultrasound-mediated oscillations and destruction of microbubbles. Multiple mechanisms are involved in the occurrence of sonoporation, including ultrasonic parameters, microbubbles size, and the distance of microbubbles to cells. Recent advances are beginning to extend applications through the assistance of contrast agents, which allow ultrasound to connect directly to cellular functions such as gene expression, cellular apoptosis, differentiation, and even epigenetic reprogramming.

Credit: 
Compuscript Ltd

Scientists urge for investment now in highly potent vaccines to prevent the next pandemic

LA JOLLA, CA--As new COVID-19 variants begin to throw vaccine efficacy in question, two leading scientists are calling for health agencies to invest in the development of vaccines that would be broadly effective against many different variants and strains of potential pandemic viruses.

In a commentary article published in the journal Nature, Dennis Burton, PhD, and Eric Topol, MD, of Scripps Research call for governments to provide significant funding support for rational vaccine design based on broadly neutralizing antibodies.

Such antibodies provide broad-spectrum potency against viruses, a valuable characteristic that opens the door to vaccines that could provide immunity against the many variants that might evolve from a fast-mutating virus. They could also be used as drugs to prevent and treat infections.

Burton and Topol note that the rapid development of effective vaccines against COVID-19 was possible due to certain properties of the SARS-CoV-2 virus--in particular, the spike protein on the virus's surface. But they warn that the virus driving the next pandemic may not provide such a ready target, which could substantially slow the process of developing a novel vaccine.

"Even SARS-CoV-2 could be becoming more problematic for vaccines because of the emergence of new variants," they write. "We call for an alternative approach to pandemic preparedness."

Burton and Topol point to broadly neutralizing antibodies as a promising avenue for developing vaccines and therapies that might be readily adapted to newly emerged pandemic viruses or those that rapidly evolve to evade traditional vaccines.

"Such antibodies could be used as first-line drugs to prevent or treat viruses in a given family, including new lineages or strains that have not yet emerged," the write. "More importantly, they could be used to design vaccines against many members of a given family of viruses."

Of particularly concern for future pandemics are viruses that are "evasion-strong," meaning their biological characteristics make them challenging to treat with drugs or prevent with vaccines. The extreme example of this type of virus is HIV, which can stay in the body for years, hiding from the host's immune system.

Burton and his colleagues at Scripps Research and other organizations are currently developing vaccines based on broadly neutralizing antibodies in hopes of producing the world's first truly effective HIV vaccines.

They are also seeking to employ broadly neutralizing antibodies as therapies and vaccines against influenza, another evasive virus and prime contender for future pandemics.

"Such pan-virus vaccines could be made in advance and deployed before the next emerging infection becomes a pandemic," Burton and Topol write. "We call for an investment now in basic research leading to the stockpiling of broadly effective vaccines."

Credit: 
Scripps Research Institute

Can current smartphone technology tell you when a pandemic might come calling?

Photoplethysmography (PPG) is a simple optical technique used to detect volumetric changes in peripheral blood circulation. It's used in smart watches, for example, to monitor pulse and heart rate, but PPG biosensors are also found in millions of smartphones, but without any current clinical applications.

In a study published online in the February 2021 issue of Chest, researchers at University of California San Diego School of Medicine, with industry collaborators, found that already embedded PPG in smartphones, in tandem with application software, could be used for remote clinical pulse oximetry to manage chronic cardiopulmonary disease and perhaps initial treatment and monitoring of persons affected in respiratory viral pandemics, such as COVID-19.

"Pulse oximetry monitoring plays an important role in managing pulmonary diseases, especially during pandemics or epidemics of respiratory viral infections, such as COVID-19 and influenza," said the study's first author Sara H. Browne, MD, an associate professor in the UC San Diego School of Medicine and an infectious disease specialist.

Oxygen saturation is a valuable component of the clinical evaluation used to differentiate those that require close monitoring. In circumstances of home quarantine, remote clinical pulse oximetry allows patients to objectively report oxygen saturation and heart rate in addition to their symptoms. Smartphone sensors with apps could facilitate access to these measurements, but to be utilized clinicians must know that these measurements are accurate and reliable.

Browne also noted there are health equity aspects in remote monitoring.

"Smartphones with sensors and apps could significantly enhance remote monitoring due to their ubiquity, and don't require patients to have additional expensive gadgets."

PPG sensors measure distention or enlargement of arteries and other vessels under the skin as blood pulses through them by detecting differences in light absorbed or reflected back to a pair of light-emitting diodes in the device. The painless, non-invasive technology is called pulse oximetry and is commonly used in hospitals and clinics, often to evaluate oxygen levels in patients' blood.

In their study, researchers recruited 10 volunteers (three Caucasian, three Black and four Asian), each placed an index finger over a smartphone sensor system with an app designed to clinically interpret the resulting optical data. The volunteers then breathed a mixture of gases with reduced levels of oxygen, sequentially declining to reach stable arterial oxygen saturations between 70 percent and 100 percent. They found that the smartphone measurements of blood-oxygen levels corresponded with other Food and Drug Administration-approved clinical tools used for this purpose.

Then, using the same smartphone, the researchers analyzed more than 2,200 readings taken simultaneously from smartphone pulse oximetry and in-hospital Welch-Allyn instruments in 320 study participants, ages 18 to 89, and representing a broad range of racial and ethnic backgrounds. They found that the smartphone readings had equivalent measurement accuracy and precision to the expensive FDA-approved hospital instruments.

Credit: 
University of California - San Diego

COVID-19 news from Annals of Internal Medicine

Below please find a summary and link(s) of new coronavirus-related content published today in Annals of Internal Medicine. The summary below is not intended to substitute for the full article as a source of information. A collection of coronavirus-related content is free to the public at https://www.acpjournals.org/topic/category/coronavirus.

Rapid, Living Practice Points from ACP: Update on remdesivir use for hospitalized COVID-19 patients

In updated Rapid, Living Practice Points (https://www.acpjournals.org/doi/10.7326/M20-8101), the American College of Physicians (ACP) addresses emerging evidence regarding the effectiveness of remdesivir in hospitalized patients with COVID-19 and whether benefits and harms vary by symptom duration, disease severity, and treatment duration. The paper, developed by the Scientific Medical Policy Committee of the ACP, Should Remdesivir Be Used for the Treatment of Patients with COVID-19? Rapid, Living Practice Points from the American College of Physicians (Version 2), was published today in Annals of Internal Medicine.

The ACP's updated Practice Points aim to target patients who will most benefit from the use of remdesivir and now suggests the following:

Consider remdesivir for 5 days to treat hospitalized patients with COVID-19 who do not require mechanical ventilation or extracorporeal membrane oxygenation (ECMO).

Consider extending the use of remdesivir to 10 days to treat hospitalized patients with COVID-19 who require mechanical ventilation or ECMO within a 5-day course.

Avoid initiating remdesivir to treat hospitalized patients with COVID-19 who are already on mechanical ventilation or ECMO.

Based on a systematic review conducted by the Minneapolis VA Evidence Synthesis Program that has been updated through Dec. 7, 2020, this version represents a change from the previous classifications of "moderate" and "severe" disease to now describe disease severity according to respiratory support requirements [e.g. no requirement, supplemental oxygen, mechanical ventilation/ECMO].

Remdesivir is a broad-spectrum antiviral agent administered intravenously. It was authorized on Oct. 22, 2020, for emergency use for the treatment of COVID-19 in the U.S. by the Food and Drug Administration and in other countries.

ACP's Practice Points are developed by ACP's Scientific Medical Policy Committee and provide advice to improve the health of individuals and populations and promote high value care based on the best available evidence derived from assessment of scientific work (e.g. clinical guidelines, systematic reviews, individual studies). ACP Practice Points aim to address the value of screening and diagnostic tests and therapeutic interventions for various diseases, and consider known determinants of health, including but not limited to genetic variability, environment, and lifestyle.

The ACP Practice Points will be maintained as a "living" document and ACP's Scientific Medical Policy Committee will monitor emerging evidence to determine its impact on the main findings and conclusions, and issue updates as needed.

Media Contacts: The full text of the article is free to the public. Click on the link above to access the text. To speak with someone from ACP, please contact Andrew Hachadorian at AHachadorian@acponline.org
or (215) 351-2514.

Credit: 
American College of Physicians

Why does love of bargain hunting run in families?

Headlines like "Black Friday Shoppers Trampled in New York" and popular television shows such as "Extreme Couponing" remind us how crazy consumers can get about retail sales promotions. This enthusiasm for getting bargains has been termed "deal proneness."

Past research has indicated that, to some degree, people become deal prone through being taught by their parents. But a new paper, "Born to Shop? A Genetic Component of Deal Proneness," published in the Journal of the Association for Consumer Research, provides evidence that our genes also play a role in causing bargain-hunting enthusiasm.

To demonstrate this genetic factor, authors Robert Schindler, Vishal Lala, and Jeanette Taylor compared the deal-proneness similarity among 78 pairs of identical (monozygotic) twins with that among 43 pairs of fraternal (dizygotic) twins reared together. They measured interest in various types of deals, like promotions that involve discounts (e.g., "Receiving cash rebates makes me feel good") and promotions that involve bonuses (e.g., "I enjoy buying products that come with a free gift"). The results indicated that 70 percent of the variability in deal proneness is associated with variability in genetic factors.

"The greater deal-proneness similarity among identical twins than among fraternal twins provides strong evidence for the existence of a heritable component to deal proneness," the authors write. However, the fraternal twins who lived together did show more similarity in deal proneness than those who did not live together, which the authors note is evidence that it's not all heredity - shared experience also is a source of deal proneness.

Knowing that interest in bargains runs in families might suggest to retailers the value of using parent-child, grandparent, or other family settings in communicating about deals. However, this research also raises the question of how such a modern, culturally-dependent phenomenon such as deal proneness could be, even partially, in our genes. Future research that will help answer this question may also guide us to a deeper understanding of the sources of consumers' often striking enthusiasm for retail bargains.

Credit: 
University of Chicago Press Journals

Environmentally friendly behavior is easy -- tourists just need a 'nudge'

image: Poster used in the study to stimulate environmentally friendly behavior, through a negative message

Image: 
K. Nelson and coauthors

A new study in Frontiers in Communication has demonstrated the powerful impact that subtle messaging and cues, or 'nudges', can provide on encouraging people to show socially desirable behaviors. Travelers who were observed on the Indonesian island of Gili Trawangan, a popular tourist destination, were more likely to demonstrate environmentally conscious actions, such as refusing a plastic bag or avoiding contact with a coral reef, when they were 'nudged' towards the desirable action with either a written or face to face interaction. The researchers found that any intervention, whether framed positively or negatively, was enough to lead people to make environmentally conscious decisions, compared to being given no behavioral cues or messaging. The study provides many practical takeaways that can be easily implemented by tourist operators or businesses, at a low cost, to increase environmental stewardship and promote positive behaviors in their customers.

Although many of us feel a responsibility to demonstrate environmentally-conscious behaviors and possess the knowledge we need to take these actions, we are often burdened by numerous obstacles, a phenomenon the researchers describe as the 'knowledge-action gap'. Dr Katherine Nelson, who led the study in partnership with the Gili Eco Trust, explains:

"The gap between knowledge and action exists because it is much easier to think a certain way than it is to actually consistently behave in that manner -- but providing a subtle cue can help us relieve some of the cognitive burden on our brains when we are in a complex environment."

To try and close this gap, the researchers set up scenarios for tourists in two real life situations -- when being offered a plastic bag at a convenience store, and when given a briefing before a snorkeling trip. The researchers observed the differences in people's behavior based on whether a person was confronted with a written or face to face interaction of either a positive message highlighting good outcomes, or a negative message focusing on the bad outcomes of a specific action.

The study showed that the presence of a 'nudge' or cue towards certain behaviors was enough to encourage people to behave in more environmentally conscious ways, whether that was refusing a plastic bag whilst at the convenience store or ensuring they maintained a safe distance from turtles when on a snorkeling trip - whether this message was framed positively or negatively did not matter.

"Our study highlights that an intervention can lead people to making better decisions by just drawing their attention to an issue -- by providing a small cue, we can reduce the obstacles that get in the way and make environmental behaviors easy."

The results offer important insights on the effectiveness of simple messaging as a practical way to nudge people towards environmentally conscious behaviors. The tourist sector in particular has huge potential to utilize these types of approaches and make pro-environmental behaviors a simple choice to reduce local impacts.

Credit: 
Frontiers

Peanut allergy affects even more U.S. adults than children

KEY STUDY FINDINGS INCLUDE:

2.9% of U.S. adults report a current peanut allergy.

About one in six adults with a peanut allergy developed it after age 18.

Approximately one in five adults with peanut allergy report visiting the emergency department for food allergy treatment each year.

Patients who developed their peanut allergy during adulthood are less likely to report having an epinephrine auto-injector prescription than those who developed their peanut allergy during childhood, despite similar frequencies of severe reactions among both groups.

CHICAGO --- Peanut allergy affects at least 4.5 million adults in the U.S., many of whom report developing their first allergy symptoms during adulthood, reports a new Northwestern Medicine study.

However, despite the fact that roughly three out of four Americans with peanut allergy are over 17 years old, peanut allergy is often considered a predominantly pediatric concern. For example, earlier this year the U.S. Food and Drug Administration (FDA) approved a peanut allergy therapy for initiation in pediatric patients ages 4-17. There are currently no FDA-approved therapies for patients with adult-onset food allergy.

The new study provides the first detailed estimates of peanut allergy among U.S. adults in all 50 states, which was previously unknown. These data indicate peanut allergy may be more common than previously acknowledged, and while younger adults are most affected, peanut allergy impacts U.S. adults of all ages.

"Currently, the sole FDA-approved peanut allergy therapy--Palforzia-- is only indicated for pediatric patients. Given the high prevalence of peanut allergy among U.S. adults, additional therapies are needed to help address this growing burden of disease," said senior study author Dr. Ruchi Gupta, professor of pediatrics at Northwestern University Feinberg School of Medicine and a physician at Ann & Robert H. Lurie Children's Hospital of Chicago.

Gupta also is director of the Center for Food Allergy and Asthma Research at Feinberg.

The paper will be published Feb. 9 in the Journal of Allergy and Clinical Immunology.

The study found 2.9% of U.S. adults report a current peanut allergy, while 1.8% report a physician-diagnosed peanut allergy and/or a history of peanut-allergic reaction symptoms. In addition, researchers found two in three adults with peanut allergy have at least one other food allergy--most commonly tree nuts but more than one in five are also allergic to shellfish.

The data also indicate many individuals who report peanut allergies and experience potentially severe allergic reactions are not obtaining clinical diagnosis of their allergies.

"Clinical confirmation of suspected food allergies, no matter when their reported onset, is critical to reduce the risk of unnecessary allergen exposure as well as to ensure patients receive essential counseling and prescription of emergency epinephrine," said study co-first author Dr. Dawn Lei, a clinical instructor of pediatrics at Feinberg and an allergist and immunologist at Edward Hines Jr. VA Hospital.

Christopher Warren, director of population health at Feinberg's Center for Food Allergy and Asthma Research and co-first author added, "Unlike allergies such as milk or egg, which often develop early in life and are outgrown by adolescence, peanut allergy appears to affect children and adults to a similar degree. Our study shows many adults are not outgrowing their childhood peanut allergies, and many adults are developing peanut allergies for the first time.

"Worryingly, despite reporting similar rates of severe reactions and annual food allergy-related emergency room visits, patients with adult-onset peanut allergy were less likely to report a physician-diagnosis as well as a current epinephrine prescription."

Together, these data suggest additional efforts are needed to ensure optimal food allergy diagnosis and management among adults with peanut allergy, study authors said.

Credit: 
Northwestern University

Phages can anticipate bacteria's location and destroy them before they cause an infection

Researchers at Baylor College of Medicine and other institutions have identified a novel strategy that can eliminate bacteria in a specific location before they cause an infection. The strategy uses a phage, a virus that infects and destroys bacteria, that can specifically locate in the same place the bacteria live in the gastrointestinal tract. The proximity between phage and bacteria facilitates the phage's attack and subsequent elimination of the bacteria.

This strategy has the potential of becoming a game changer in the fight against antibiotic-resistant bacteria that live in hard-to-reach places, such as the mucus layer of the gut. The study appears in the journal mBIO.

"Phages are very specific in their ability to infect and destroy certain species or strains of bacteria and not others, such as good bacteria. In the U.S., phage therapy is increasingly becoming an available option to treat antibiotic-resistant bacterial infections, a serious health concern," said first author Dr. Sabrina Green, director of research and development for TAILΦR labs at Baylor.

Antibiotic-resistant bacteria, such as ExPEC ST131, can colonize the human intestine without causing disease, but they also can exit the gut and infect other organs. For instance, these bacteria have been associated with infections of the urinary tract, brain, peritoneum, peripheral organs, blood and in-dwelling devices, such as urinary catheters, vascular devices, feeding tubes and wound drains, resulting in 9 million infections per year.

The team showed in previous work that phages can effectively treat an infection caused by ExPEC ST131 bacteria. In this study, they wanted to see if they could use phages to remove these bacteria to prevent an infection.

Finding the right phage

Many phages have a hard time fighting bacteria in the gut. The team discovered that there is a factor present in mammalian intestines that prevents phages from destroying bacteria. They identified the factor as mucin, sticky proteins that form a layer between intestinal epithelial cells and the layer of microorganisms.

The researchers reasoned that although mucins prevent many phages from infecting bacteria, there may be some that have evolved a way to counter the effect of mucins and, as a result, are able to target bacteria in high-mucin environments.

"We screened human sewage and animal feces for phages with unique properties that facilitate their ability to destroy bacteria in the presence of mucins," said corresponding author Dr. Anthony Maresso, associate professor of molecular virology and microbiology at Baylor. "We discovered a novel phage called ES17 that binds to mucins, and this property seemed to enhance its ability to infect bacteria in mucin-rich environments, such as the gut."

Further studies looked closer at this novel phage-mucin interaction. Green, Maresso and their colleagues discovered that phage ES17 binds to particular molecules called heparan sulfate which can be found not only in mucins, but also on the surface of various cells types, including epithelial cells. This prompted the researchers to investigate whether binding to heparan sulfate on epithelial cells, which the researchers had also discovered is the same binding site used by ES17's host bacteria ExPEC, would contribute to ES17's ability to target and destroy the bacteria in the gut environment.

"We tested the effect of phage ES17 on its bacterial host ExPEC in a murine intestine, comparing it with phages known to be unable to infect their bacterial host in complex environments," Green said. "We found that only ES17 had the unique ability to target and eliminate ExPEC bacteria in animal models."

A novel strategy to prevent bacterial infections

Taken altogether, the findings suggest that the ability of phage ES17 to bind to heparan sulfate on mucin-rich surfaces and directly on mammalian epithelial cells mediates its localization in areas deep in the gut where reservoirs of bacteria may be present. The researchers propose that being close to ExPEC bacteria facilitates phage invasion and bacterial elimination before they have the opportunity to exit the gut and infect other organs.

"Phages are viruses that specialize in invading and eliminating specific bacteria. Here we have shown the first phage that also binds to epithelial human cells and that this property mediates a novel mechanism for fighting bacterial infections we call positional targeting, as it enables the phage to anticipate where the bacteria it targets will be located," Maresso said. "We foresee the possibility that positional targeting will be the way smart drugs work in the future. Drugs won't be just distributed all through the body in the hopes that some of it will end in the right spot. The drugs of the future will go only precisely where they are supposed to work. Our work with phages is the first case in which this has been achieved."

Credit: 
Baylor College of Medicine

A new type of university is emerging to meet the challenges of today

The world is changing rapidly and in order to serve the human population dealing with those changes, American universities need to change, too. In fact, their role is to model the resiliency that all institutions need to embrace, according to Arizona State University President Michael M. Crow.

While many leading universities are poised to advance society and help respond to the challenges of disruptive change through their traditional role in education and discovery, many face a number of barriers that make them less prepared to respond to the rapidly changing conditions and the demands they create.

What is emerging is a new type of university, one that steps beyond the American research university model and is nimble and responsive, takes responsibility for what happens outside its walls and can scale up to meet the demands and challenges of modern society. ASU President Michael Crow says they are part of the "fifth wave" of universities.

Crow's comments came today (Feb. 9, 2021) at the annual meeting of the American Association for the Advancement of Science. Crow's presentation, "A new evolution of research universities," touched on the history of universities, outlined the challenges they face today and explained how new universities of the fifth wave will rise to meet those challenges.

In his recent book "The Fifth Wave," (written with ASU senior research fellow William Dabars) Crow describes the emerging standard of research universities that will better align them with the needs of society in many ways, including contributing solutions to global problems.

The fifth wave is a manifestation of a new wave of American universities, a model embraced and advanced by Arizona State University. These universities are egalitarian, accessible, based in community impact and measured against social outcomes. They are scalable, they are technologically sophisticated and advanced. They educate not hundreds of students, but thousands and tens of thousands of students, Crow said.

Many of today's leading universities are American research universities, which emerged nearly 140 years ago - the fourth wave of university evolution. These universities have a long history of contributions to society, such as breakthrough advances in the fundamental understanding of nature, advancing applied science on a multitude of fronts, and advancing human culture, human's sense of place and sense of self.

"This has all has been fantastic, but inadequate," Crow said. "Because what happened during the evolution of the research university is that it has become more exclusive, more limited to smaller and smaller fragments of society, and more and more isolated from larger aspects of society itself."

The COVID-19 pandemic is a case in point on the limits of the traditional research university.

"America's universities were about as unprepared for this pandemic as one could possibly imagine," Crow said. "Suddenly, we didn't know how to communicate science well enough, we didn't know how to engage in complexity well enough, we didn't know how to cut and cross between disciplines well enough, and we didn't know how to build confidence around knowledge well enough."

The pandemic shows that what is needed is an additional type of university, not a replacement for the ones that exist and are exemplars today, but an additional type of higher educational institutions. "The fifth wave will allow us to do it," Crow said.

The "new" universities are responsive to the rapidly evolving needs of society. Their hallmarks include being inclusive in their educational philosophy and understanding that all people are lifelong learners; contributing to the challenges humans face today on a grand scale, like climate change and the current pandemic; taking stock in their immediate surroundings and being responsible for the success of that setting and of society as a whole.

"We are faced with an evolutionary moment. The role of the university, its role in discovery, its role in creativity, its role in innovation has never been more important and also its limits have never been clearer," Crow said. "The significant role going forward is figuring out the role of existing research universities and the role of emerging universities, including those that need to operate at a new scale, a new speed and a new egalitarianism."

Crow warned, though, that certain barriers exist that can thwart the evolution of fifth wave universities.

"We form athletic leagues, but we don't form climate change research leagues," he said. "The current model is to have faculty largely work in small centers and small groups, each attempting to advance their fields in a highly competitive way to beat out their competitors. This leaves little room for working on the scaled problems, like how do we manage our relationship with the planet, how will we facilitate cultural and economic competitiveness and do so to the benefit of a highly diverse population. How do we map between Western science, Western culture, Western technology and Indigenous science, Indigenous culture and Indigenous technology?"

Crow explained that in shaping the New American University model is the idea that the university will take responsibility for actions outside of the institution itself.

"If K-12 is underperforming, the institution is partly responsible," Crow said. "If 50% of students graduating from high school are inadequately prepared for the society in which we live, the universities and colleges are partly responsible."

Once the institution takes on that responsibility outside of its walls, then its contribution to society becomes real in a daily way.

"Then we will have the emergence of a new type of American research university, one which is devoted to the actual measured success of the society in which it is embedded," Crow added. "Not in an abstract intergenerational way but in a functional way. In a day-to-day way."

Credit: 
Arizona State University

How diseases and history are intertwined

Today, the average American is unlikely to spend time worrying about malaria. Although the disease is commonly perceived to be restricted to other parts of the world, it played a significant role in shaping American history. It even helped turn the tide of the American Revolutionary War by infecting so many British soldiers that General Cornwallis was forced to surrender at Yorktown.

First-year students in a 2019 introductory seminar class led by Erin Mordecai, an assistant professor of biology in the School of Humanities and Sciences (H&S), delved into this and other historical examples of how vector-borne diseases - those caused by infectious pathogens spread by living organisms or "vectors" - influenced human history. Throughout the course, they collaborated on a paper highlighting various trends in which these illnesses impacted historical societies. Their findings have now been published in the latest issue of the journal Ecology Letters.

"The mechanisms and consequences of vector-borne diseases are multimodal and far more pervasive than we had previously thought," said Tejas Athni, a student in the seminar and first author of the paper.

As Athni and his fellow students conducted their research, they discovered recurring themes across societies throughout time. One theme was that diseases don't affect all populations equally - a simple fact that had major ramifications throughout history. In the case of the American Revolution, many Americans had grown up in the South and were exposed to malaria young, allowing them to develop immunity. This granted them a strategic advantage over the less immune British army, which ended up being decimated by the disease.

A more sobering trend unearthed by the group's investigations was that disease tended to prey on inequities in societies, leaving marginalized groups most at risk. Both intentionally and unintentionally, it was weaponized time and again to enforce unjust hierarchies of power. In the American South, for instance, enslaved Black people were often forced to work in conditions that left them exposed to mosquitoes and made them much more vulnerable to malaria. To make matters worse, this inequity was used by white people to encourage the racist belief at the time that Black Americans were morally inferior and to justify Jim Crow segregation laws in the South.

Racism and disease

When Mordecai first submitted her class's paper for journal publication, it was rejected, with one reviewer citing the paper's failure to explore the relationship between racism and disease. Taking a more interdisciplinary approach, Mordecai then invited the reviewer, Nita Bharti, the Huck Early Career Professor of Biology at Penn State University, and Steven O. Roberts, an assistant professor of psychology in H&S and a race scholar, to speak to her class about systems of inequality from psychological and historical standpoints.

"We were taken aback by the extent to which the impacts of vector-borne disease have historically splintered across racial and societal lines," said Athni.

Structural racism, including what neighborhoods people can live in and their access to intergenerational wealth, is linked to disparities in rates of diabetes, hypertension and other chronic diseases associated with stress, Mordecai explained. These disparities are also apparent in the COVID-19 pandemic, where the disease's outcomes are more serious for individuals suffering with these conditions. This disproportionate burden further amplifies the vulnerability of already disadvantaged communities.

"When you layer on an emerging pandemic with existing health disparities, it disproportionally affects Black and Hispanic communities," said Mordecai.

Racial disparities also put historically marginalized communities at greater risk of being exposed to the virus. These communities, for instance, are more likely to be essential workers, lacking the luxury to safely shelter in place or have their groceries delivered.

"It's easy to think that communities of color aren't social distancing enough or not practicing proper hygiene," said Roberts, who is a co-author on the paper. "But that thinking completely neglects the social conditions that have made those communities more vulnerable to begin with."

The relationship between COVID-19 and structural inequality is unfortunately not limited to just modern times or the U.S. This too is a pattern that has repeated throughout history and across the globe. Outbreaks of leishmaniasis, a vector-borne disease spread by phlebotomine sand flies, have impacted hundreds of thousands of Syrians within refugee camps, a result of overcrowding in areas with poor sanitation. And when the first few cases of the Ebola outbreak popped up in 2014 in Africa, scientists in the United States were slow in finding ways to combat it until it showed up closer to home.

The authors hope that this paper will motivate scientists to be more proactive in protecting people in historically disadvantaged communities from disease.

"The paper does a spectacular job documenting the problem," said Roberts. "Now it will be important to maintain an interdisciplinary focus that can dismantle it."

Centering equity

Mordecai believes the paper produced as a result of her class is unique in the ecological literature. As the work underwent the peer review process, editors originally commented that it didn't feel like an ecological study at all. However, since the Black Lives Matter protests in the spring of last year, she said she is seeing a growing number of epidemiologists recognizing the role of racism in infectious disease transmission.

Athni, now a junior working on his honors thesis on statistically modeling the effects of climate on global mosquito distributions, said that being involved in this project has influenced the way he conducts research as a growing biologist.

"Dr. Mordecai's freshman seminar shaped my entire Stanford journey through an interdisciplinary lens," Athni said. "Moving forward, it's imperative that research explicitly recognizes and combats the structural racism, classism and sexism that continue to perpetuate environmental and health inequities. Equity must be brought to the center of ecology and global health in order to make meaningful progress for all of humanity."

Credit: 
Stanford University